SG/CALL/ZOETIS/210/0.1/20.12.24 | Market Closed - Bid/Ask 03:43:19 2024-07-11 pm EDT | After market 03:59:37 pm | |||
| 0.5 EUR | +19.05% |
|
0.505 | +1.00% |
| Current month | +4.08% | ||
| 1 month | -19.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.5 | +19.05% |
| 24-07-10 | 0.42 | -6.67% |
| 24-07-09 | 0.45 | -8.16% |
| 24-07-08 | 0.49 | 0.00% |
| 24-07-05 | 0.49 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update July 11, 2024 at 03:43 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | 
Société Générale
|
| WKN | SU2YLC |
| ISIN | DE000SU2YLC2 |
| Date issued | 2023-11-29 |
| Strike | 210 $ |
| Maturity | 2024-12-20 (162 Days) |
| Parity | 10 : 1 |
| Emission price | 1.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.17 € |
|---|---|
| Lowest since issue | 0.15 € |
| Spread | 0.01 € |
| Spread % | 1.92% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
173.5
USD
Average target price
210.2
USD
Spread / Average Target
+21.13%
- Stock Market
- Warrants
- Warrant
